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Background: Adipose tissue normally contains immune cells that regulate adipocyte function and contribute to
metabolic disorders including obesity and diabetes mellitus. Psoriasis is associated with increased risk for metabolic
disease, which may in part be due to adipose dysfunction, which has not been investigated in psoriasis. There is
currently no standardized method for immunophenotyping human adipose tissue. In prior studies, characteristic
phenotypic markers of immune cell populations identified in animal models or in other human tissues have been
applied in a similar manner to human adipose tissue. Rarely have these populations been verified with confirmatory
methodologies or functional studies. Thus, we performed a comprehensive phenotypic and functional analysis of
immune cell populations in psoriatic adipose tissue.
Methods: Conventional and imaging flow cytometry were used to define immune cell populations in biopsy
specimens of psoriatic adipose tissue (n = 30) including T cells, B cells, NK cells, NKT cells, neutrophils, and macrophages.
Relationships between adipose immune cell types and body mass index were determined using Spearman regression
analysis, and multivariate linear regression analysis was performed to adjust for cardiometabolic disease risk factors.
Results: These analyses revealed a wide range of cell surface receptors on adipose tissue macrophages, which may
serve a dual purpose in immunity and metabolism. Further, both CD16+CD56Lo and CD16-CD56Hi NK cells were
found to correlate inversely with body mass index. The relationship between the predominant CD16+CD56Lo NK
cell population and body mass index persisted after adjusting for age, sex, diabetes, and tobacco use.
Conclusions: Together, these studies enhance our understanding of adipose immune cell phenotype and
function, and demonstrate that examination of adipose tissue may provide greater insight into cardiometabolic
pathophysiology in psoriasis.
Keywords: Adipose tissue, Immunophenotyping, Imaging flow cytometry, PsoriasisIntroduction
Adipose tissue plays important roles in energy storage,
thermal equilibrium, endocrine function, and immunity
[1]. Immune cells within adipose tissue from healthy
humans have been implicated in homeostatic functions
as well as the initiation and maintenance of metabolic
diseases such as obesity and diabetes [2]. Animal models* Correspondence: nehal.mehta@nih.gov
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unless otherwise stated.have shown that adipose immune cells contribute to obes-
ity and insulin resistance, including T cells [3-7], B cells
[8,9], dendritic cells [10,11], neutrophils [12,13], mast cells
[14], and adipose tissue macrophages [ATM] [15-17],
while eosinophils [18] and T regulatory cells (Tregs) may
protect against insulin resistance [19,20], and NKT cell
function is equivocal [21-24]. Adipose specimens from
obese humans have demonstrated increased frequencies
of T cells [3,25], dendritic cells [10], mast cells [14], neu-
trophils [26,27], and macrophages [16,28]. In contrast,
obese humans have reduced numbers of adipose NKT
cells [21] and either an increased [29] or decreased [30]
Treg cell mRNA signature compared to lean individuals.
CD56+ NK cells have also been demonstrated in humand. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tion has been shown to be reduced in obesity [31].
Immunophenotyping studies of human adipose have
generally assumed that characteristic markers of im-
mune cells described in animal models or in other hu-
man tissues can be applied similarly to adipose tissue. A
major limitation of prior studies has been a paucity of
data confirming flow cytometric analysis with alternative
methods of cellular identification. Further, the cadre of
markers identified on human adipose immune cells re-
mains limited. Here, we have overcome these deficien-
cies by utilizing cutting-edge conventional and imaging
flow cytometry to characterize the immune cell content,
phenotype, and function in adipose specimens from pa-
tients with the inflammatory skin condition psoriasis,
which is associated with an increased risk of cardiometa-
bolic disease (CMD), [33] and adipose tissue dysfunction
[34]. We have identified innate and adaptive immune
cell populations, and present a panel of ATM markers
that may have dual roles in metabolism and immunity.
We have also characterized a NK cell population that
correlated inversely with body mass index (BMI). To-
gether, these studies are the first to characterize the im-
mune cell repertoire within psoriatic adipose tissue, and
may offer insight into the mediators of CMD in psoriasis.
Methods
Study population
Subcutaneous gluteal adipose tissue biopsies were per-
formed in psoriasis patients (n = 30) aged 18 to 70
years in a consecutive sample from the Psoriasis
Atherosclerosis and Cardiometabolic Disease Initiative
(PACI; NCT01778569). A dermatologist confirmed the
diagnosis of plaque psoriasis, and performed body sur-
face area (BSA) and Psoriasis Area and Severity Index
(PASI) assessments. Psoriatic arthritis was confirmed by
a rheumatologist. Exclusion criteria included history of
another systemic inflammatory illness, myocardial in-
farction, stroke, or chronic infectious disease. Study ap-
proval was obtained from the National Heart Lung and
Blood Institute (NHLBI) institutional review board in
accordance with the Declaration of Helsinki. All study
participants provided written informed consent.
Serum factor determination
Fasting levels of total, HDL, and LDL cholesterol, tri-
glycerides, glucose, erythrocyte sedimentation rate (ESR)
and high-sensitivity C-reactive protein (hsCRP) were
measured in a clinical laboratory.
Adipose tissue immune cell preparation
Adipose tissue specimens were collected in RPMI
medium and minced into fine pieces using scissors after
careful removal of infiltrating blood vessels with forcepsand scissors. Samples were digested in 5 mg/mL Type IV
collagenase (Life Technologies, Grand Island, NY) for
30 minutes at 37°C in an Eppendorf thermomixer
(Sigma-Aldrich, St. Louis, MO) at 1300 RPM. Tissue
fragments were passed through a 40 μM nylon filter (BD
Falcon, Beford, MA), washed twice with 1X PBS, and the
floating adipocyte fraction was removed by vacuum as-
piration. Blood contamination was determined by the
visible presence of large amounts of erythrocytes in the
cell pellet after digestion and centrifugation. Further,
blood contaminated samples demonstrated abundant
granulocyte populations by flow cytometry that are not
typically present in adipose tissue. Three adipose sam-
ples were excluded from the analyses due to blood
contamination.
Conventional flow cytometry
Adipose immune cells were stained with various cocktails
(up to 15-parameter) of surface antibodies in staining buf-
fer [1X PBS without calcium or magnesium containing 5%
heat-inactivated fetal bovine serum (Atlas, Fort Collins,
CO), 0.25 mM EDTA (Sigma-Aldrich), and 0.09% sodium
azide (Sigma-Aldrich)] for 30 minutes at 4°C. A 1:500 so-
lution of LIVE/DEAD Aqua (Life Technologies) was added
during the last 10 minutes of staining. For samples requir-
ing intracellular staining, cells were fixed and perme-
abilized using BD Cytofix/Cytoperm kits (BD Biosciences,
San Jose, CA) according to the manufacturer’s instruc-
tions, followed by intracellular staining for 30 minutes at
4°C. T cell IFN-γ and TNF-α production was elicited by
incubation with 10 ng/mL PMA (BD Biosciences) and
1 μg/mL ionomycin (BD Biosciences) in the presence of
10 μg/mL brefeldin A (BD Biosciences) for 3 hours prior
to intracellular cytokine staining. FoxP3, granzyme B, IL-
1α, and IL-8 were assessed in unstimulated cells without
using a protein transport inhibitor. Foxp3 staining was
conducted similarly to other intracellular antigens, except
that Foxp3 staining kits (eBioscience, San Diego, CA) were
used. Positive staining for each antibody-fluorochrome
combination was determined using fluorescence minus
one (FMO) controls. Additional file 1: Table S3 lists the
antibodies utilized for conventional and imaging flow cy-
tometry. Samples were acquired on a BD Biosciences LSR
II flow cytometer equipped with 405 nm, 488 nm, 532 nm,
and 633 nm excitation lasers using DIVA software (BD
Biosciences). Compensation was performed with single
color controls prepared using BD Biosciences CompBeads.
Compensation matrices were calculated automatically
followed by manual adjustment and sample analysis using
FlowJo software (Tree Star, Ashland, OR).
Phagocytosis assays
Peripheral blood mononuclear cells (PBMC) were pre-
pared over a Ficoll gradient using standard methods.
Table 1 Patient characteristics
(n = 30) Median (IQR)
Age (years) 54 (41–61)
Male, count (%) 35 (54)
Psoriasis Disease Duration (years) 20 (9–32)
Body Surface Area Score [Mean (SD)] 9.2 (16)
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or adipose biopsy specimens utilizing CD14 MicroBeads
(Miltenyi Biotech, San Diego, CA), followed by passage
over MACS LS columns (Miltenyi Biotech) according to
the manufacturer’s instructions. Enrichment of CD14+
ATM was ~6-fold compared to ~20-fold enrichment of
CD14+ monocytes from PBMC. Phagocytosis assays were
performed on CD14+ monocytes, CD14+ enriched adi-
pose specimens, and whole adipose specimens using the
pHrodo (Life Technologies) system. Cells were incubated
(≥5 x 105 per well) in 96-well plates containing complete
DMEM medium (Life Technologies) for 1.5 hours at 37°C.
Culture supernatants were removed by aspiration, and op-
sonized pHrodo S. aureus bioparticles (Life Technologies)
were added to the cells for 1.5 hours at either 37°C or 4°C
(negative control). Cells were washed in staining buffer
and stained for surface antigens prior to flow cytometric
analysis.PASI Score [Mean (SD)] 7.8 (9.3)
Psoriatic Arthritis, count (%) 25 (38)
DMARD Therapy, count (%) 6 (9)
Biologic Therapy, count (%) 25 (39)
NSAID Therapy, count (%) 15 (23)
Phototherapy, count (%) 3 (5)
Topical Steroid Therapy, count (%) 24 (37)
Systemic Steroid Therapy, count (%) 1 (2)
Diabetes Mellitus, count (%) 7 (11)
Hypertension, count (%) 21 (32)
Dyslipidemia, count (%) 44 (68)
Current Tobacco Use, count (%) 6 (9)
Former Tobacco Use, count (%) 18 (28)
Diabetes Mellitus Therapy, count (%) 4 (6)Imaging flow cytometry
Surface staining was performed as described above. Cells
were washed with 1X PBS buffer containing 0.5 mM
EDTA and 0.2% BSA at pH 7.2, suspended at a concentra-
tion of 1–5 × 106/mL, and then incubated in 0.1 mM
Hoechst (Life Technologies) at 37°C for 30 minutes. Posi-
tive staining for each antibody-fluorochrome combination
was determined using FMO controls. Samples were ac-
quired on an Amnis ImageStream X Mark II instrument
equipped with 405 nM, 488 nM, 561 nM, and 640 nM la-
sers utilizing INSPIRE software (Amnis, Seattle, WA).
Automatic compensation was performed with single color
controls (BD Comp Beads), followed by manual adjust-
ment and analysis using IDEAS 6.0 software (Amnis).Anti-Hypertensive Therapy, count (%) 12 (19)
Dyslipidemia therapy, count (%) 24 (37)
Body Mass Index (kg/m2) 29 (25.9-32.3)
Systolic Blood Pressure (mm Hg) 125 (116–135)
Diastolic Blood Pressure (mm Hg) 72 (65–78)
Fasting Blood Glucose (mg/dL) 94 (89–104)
Total Cholesterol (mg/dL) 184 (158–203)
Triglycerides (mg/dL) 108 (84–137)
High-Density Lipoprotein Cholesterol (mg/dL) 52 (42–63)
Low-Density Lipoprotein Cholesterol (mg/dL) 96 (80–125)
Erythrocyte Sedimentation Rate (mm/hr) 8 (5–13)
High-Sensitivity C-Reactive Protein (g/dL) 1.7 (0.7-4.2)
IQR = Interquartile Range, PASI = Psoriasis Area and Severity Index,
DMARD = Disease-Modifying Anti-Rheumatic Drug, NSAID = Non-Steroidal
Anti-Inflammatory Drug. Data are reported as median (IQR) unless indicated
otherwise.
DMARD therapy denotes methotrexate use, except for 1 patient who was
taking both methotrexate and hydroxychloroquine. Biologic therapy indicates
active TNF antagonist or anti-IL-12/23 receptor use except for one patient who
was treated with abatacept for psoriatic arthritis.Statistical analysis
Spearman correlations were performed between adi-
pose NK Cell frequencies and BMI, and multivariate
linear regression was used to adjust for CMD risk
factors (age, sex, diabetes, and tobacco use) and for
treatment with oral corticosteroids, disease-modifying
anti-rheumatic drugs (DMARDs), and/or biologic agents.
No significant effects of treatment were identified. Thus,
we report results from multivariate linear regression mod-
eling after adjustment for CMD risk factors. Kruskall-
Wallis testing with post-hoc Dunn’s multiple comparisons
testing was performed to compare MFI values for surface
markers among ATM populations. Adipose cell popula-
tions and cytokine expression were compared between
psoriasis and control patients using Mann–Whitney U
tests. Significance was considered at p < 0.05. Statistical
tests were performed using Graphpad Prism (LaJolla, CA)
and STATA (College Station, TX) software.Results
Patient demographics and clinical evaluation
Patient characteristics (n = 30) and laboratory measure-
ments are presented in Table 1. Our study population
had a median age of 54 years [interquartile range (IQR)
41–61], was 54% male, had a median BMI of 29 (IQR
25.9-32.3), had moderate psoriasis (mean BSA 9.2 ± 16,
mean PASI score 7.8 ± 9.3), and 38% had psoriatic arth-
ritis (Table 1). Medication usage and CMD were also
assessed. Topical steroid use was common (37%) and 3
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apy (39%) was more common than DMARD (9%) treat-
ment (Table 1). Hypertension (32%), dyslipidemia (68%),
diabetes (11%), and tobacco use (9% active, 28% former)
were prevalent in our study population (Table 1), as was
treatment for hypertension (19%), dyslipidemia (37%),
and diabetes (6%).
Adipose immune cell characterization
Multi-parameter flow cytometry was applied to psoriatic
adipose tissue, and gating strategies for cell identification
(Figures 1, 2) and immune cell frequencies (Additional
file 2: Table S1) are presented. Together, ATM (CD3-
CD14+CD15-CD16-CD19-CD56-, Figure 1) were the most
numerous immune cell type, comprising ~10% of viable
cells. ATM made the prototypical cytokines IL-1β and IL-8
(Figure 1). Three populations of CD14+ ATM were identi-
fied based on HLADRII and CD206 expression (Figure 1).
The HLADRII+CD206- subset was more abundant than
the HLADRII-CD206- and HLADRII+CD206+ subsets.Figure 1 Flow cytometric characterization of macrophages, NK cells, a
tissue. After exclusion of debris, doublets, and non-viable cells, cells were i
B+, NK cells = CD14-CD15-CD16+/−CD56+/−SSClogranzyme B+, adipose tis
gated into 3 subpopulations based on HLADRII and CD206 expression. IL-1β a
All cell populations are presented as percentages of viable cells except for IL-1
which are reported as percentages of the parent population. Positive gat
fluorescence minus one (FMO) controls.Frequencies of IL-1β and IL-8 expressing cells were not
statistically different among the ATM subsets, except
that the percentage of HLADRII+CD206-IL-8+ cells
was significantly greater (p < 0.05) than HLADRII-
CD206-IL-8+ cells (Additional file 3: Table S2). T cells
(CD3+CD14-CD15-CD16-CD19-CD56-, Figure 2) col-
lectively made up ~4.5% of viable cells, and were pri-
marily αβ T cells with a predominance of CD4+ T cells.
αβ T cells were largely either effector or memory cells
(CD45RA-, Figure 2) and made the T cell cytokines
IFN-γ and TNF-α (Figure 2). CD8+ T cells, FoxP3+
Tregs (predominately CD4+, Additional file 4: Figure S1),
γδ T cells, and NKT cells were also identifiable
(Figure 2). Confirmation of NKT cell (CD3+CD14-
CD15-CD16-CD19-CD56+SSClo, Figure 2) phenotype
was attempted using alpha-gal-cer loaded CD1d tetra-
mers, but the scarcity of this population precluded
definitive characterization. NK cells (CD3-CD14-
CD15-CD16+/−CD19-CD56Hi/LoSSClo, Figures 1, 2) com-
prised ~1.5% of viable cells, were largely CD16+CD56Lond neutrophils in a representative sample of psoriatic adipose
dentified as follows: neutrophils = CD14-CD15+CD16+SSCHigranzyme
sue macrophages (ATM) = CD14+CD15-CD16-, which were further
nd IL-8 intracellular staining is presented for the total ATM population.
β and/or IL-8 expressing ATM, and Granzyme B expressing neutrophils,
ing for each fluorochrome parameter was established using individual
Figure 2 Flow cytometric characterization of B cells, T cells, NK cells, NKT cells, and neutrophils in a representative sample of psoriatic
adipose tissue. After exclusion of debris, doublets, and non-viable cells, CD16-CD19+ B cells, CD3+CD56- T cells, CD3-CD16-CD56Hi NK cells,
CD3+CD56+ NKT cells, and total CD16+ cells were identified. CD16+ cells were divided into neutrophils (CD16+SSCHi) and NK cells
(CD16+CD56LoSSCLo) based on SSC properties. CD3+ T cells were further gated into naïve and effector and/or memory (eff/mem) αβ T cell
subsets, CD4+CD8- T cells, CD4-CD8+ T cells, γδ T cells, and T regulatory (FoxP3+) cells. All cell populations are presented as percentages of
viable cells except for granzyme B, IFN-γ, and TNF-α expressing cells, which are reported as percentages of the parent population. Positive
gating for each fluorochrome parameter was established using FMO controls.
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protease granzyme B (Figure 2). B cells (CD3-CD14-
CD15-CD16-CD19+CD56-PD-1+, Figure 2, Additional
file 5: Figure S2) made up <1% of viable cells. Neutro-
phils (CD3-CD14-CD15+CD16 + CD19-CD56-SSCHi,
Figures 1, 2) were also infrequent and expressed the
characteristic marker granzyme B (Figure 2).
Verification of adipose tissue macrophage phenotype and
function
Conventional flow cytometry demonstrated various im-
mune cell subsets in psoriatic adipose tissue using classic
phenotypic markers. The ability of these markers to cor-
rectly identify adipose immune cells was confirmed by
imaging flow cytometry. This technology combines fea-
tures of brightfield microscopy, flow cytometry, and im-
munofluorescence microscopy in a single instrument,
thus allowing for high-resolution characterization of cellpopulations in tissues [35]. Imaging flow cytometry veri-
fied ATM by positive CD14 staining, abundant cyto-
plasm, and round to U-shaped nuclei consistent with
macrophage morphology (Figure 3, panels A-C). Three
subsets of ATM were present based on HLADRII and
CD206 expression (Figure 3), and ATM rarely expressed
CD16 (mean 1.47 ± 1.77%, Additional file 6: Figure S3).
Conventional flow cytometry was then performed to un-
cover ATM markers that may link metabolism and im-
munity in psoriasis (Figure 4). ATM expressed a wide
array of surface receptors with roles in microbial pattern
recognition (TLR2, TLR4), immune suppression (CD274),
cell adhesion (CD11c), cholesterol trafficking (ABCA1),
chemokine binding (CX3CR1), and macromolecule clear-
ance (CD163, SR-B1, LOX-1, MSR1, RAGE, and CD36)
(Figure 4A). Mean fluorescence intensity (MFI) values
for these receptors were strikingly different among the
macrophage subpopulations (Figure 4B). TLR2, CD11c,
Figure 3 Confirmation of immune cell populations in psoriatic adipose tissue using imaging flow cytometry. Morphologic and staining
characteristics of various cell populations delineated by conventional flow cytometry (Figures 1 and 2) were confirmed in psoriatic adipose tissue
using imaging flow cytometry. Cells were gated for positive nuclear staining that did not saturate the camera. Out-of-focus cells were excluded
using the gradient RMS function of the brightfield microscopy field. Doublets and debris were eliminated by plotting cell brightfield area against
aspect ratio. To determine nuclear morphology population characteristics, manually selected mononuclear or polymorphonuclear cells were
identified and hand tagged populations were created. The Feature Finder wizard in IDEAS software was then used to distinguish cells with similar
morphologic characteristics in the source population using the circularity and bright detail intensity features on the Hoechst imagery. Three
populations of cells were identified: CD3+CD16- T cells (panel D), CD3-CD16+ cells, and CD3-CD16- cells. CD3-CD16- cells were then gated on CD14+
cells (macrophages), followed by sub-gating based on CD206 and HLADRII (DRII) staining (panels A-C). Positive gating for each fluorochrome
parameter was established using FMO controls. Percentages of cells in each gate are presented as percentages of nucleated, focused, single cells.
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DRII+CD206+, intermediate in HLADRII+CD206-, and
lowest in HLADRII-CD206- ATM (Figure 4B). LOX-1
expression was lowest in the HLADRII+CD206-
population, CD36 expression was lowest in the HLA-
DRII+CD206+ subset, and RAGE expression was highest
in HLADRII-CD206-, intermediate in HLADRII+CD206-,
and lowest in HLADRII+CD206+ cells (Figure 4B). ATM
phagocytic function was also assessed by flow cytometry
using the pHrodo system, which utilizes bioparticles that
fluoresce only upon acidification within phagocyte endo-
somes [36]. Phagocytosis was equivalent among the 3
ATM subpopulations (Figure 4C).Verification of other adipose immune cell populations
Imaging flow cytometry confirmed other immune cell pop-
ulations in psoriatic adipose tissue. T cells were verified by
positive CD3 staining, round nuclear morphology, and
scant cytoplasm (Figure 3, panel D). To determine cell
types that express CD16 in adipose tissue, CD3-CD14-
CD16+ cells were manually categorized (hand tagged) as
having mononuclear (circular, Figure 5, panel A) or poly-
morphic (polymorph, Figure 5, panel B) nuclei. The Fea-
ture Finder wizard in IDEAS software was then used to
distinguish cells from the source population with similar
morphologic characteristics. This strategy allowed segrega-
tion of cellular debris/unfocused cells (Figure 5, panel D),
Figure 4 (See legend on next page.)
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Figure 4 Flow cytometric analysis of surface receptor expression and phagocytic function in adipose tissue macrophages. (A) ATM
populations were examined for expression of TLR2, TLR4, CD11c, CD274, ABCA1, CD163, SR-B1, LOX-1, MSR1, CD36, RAGE, and CX3CR1. CD14+
HLADRII-CD206- (green histograms), CD14+HLADRII+CD206- (blue histograms), and CD14+HLADRII+CD206+ (red histograms) cells are presented
compared to FMO control staining for each marker (orange histograms). (B) Mean fluorescence intensity values for each surface marker depicted in
(A) were compared in CD14+HLADRII-CD206-, CD14+HLADRII+CD206-, and CD14+HLADRII+CD206+ ATM. Kruskall-Wallis testing with post-hoc Dunn’s
multiple comparison testing was performed to determine whether surface macrophage marker expression was statistically different among the
different subsets. p values < 0.05 were considered to be statistically significant. (C) The pHrodo system was utilized to demonstrate phagocytosis of
opsonized bioparticles by enriched CD14+ monocytes (Monocytes, left panel, positive control), positively selected CD14+ ATM (Enriched ATM, center
panel), and whole adipose tissue, gated on CD14+ ATM (Whole ATM, right panel) by flow cytometry. Green dots represent bioparticles incubated with
antibody staining cocktail and no cells (acellular negative control). Red dots represent monocytes or ATM incubated with bioparticles at 4°C (cellular
negative control). Blue dots represent monocytes or ATM incubated with bioparticles at 37°C. Enriched ATM and Whole ATM were further gated into 3
subpopulations based on HLADRII and CD206 expression. Phagocytosis of opsonized bioparticles is depicted for each subpopulation of Enriched ATM
and Whole ATM and is reported as percentages of viable cells containing bioparticles.
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morphonuclear cells (Figure 5, panel E) within the
CD16+ population. CD16+ polymorphonuclear cells
had multi-lobed (2–3 lobes) nuclei and dense granular-
ity, characteristic of neutrophils. In contrast, CD16+Figure 5 Nuclear morphologic analysis of CD16+ cell populations in a
Imaging flow cytometry of adipose tissue immune cells was performed as in
the camera, poorly focused cells, and debris/doublets, CD3-CD14- cells w
were manually selected (Tagged) based on their nuclear morphology to
(Polymorph, panel B) cells. The Feature Finder wizard in IDEAS software w
(Automated, panels C, E) and to exclude debris and unfocused cells (Automa
imagery were the 2 characteristics that best distinguished the manually select
Tagged and Automated CD16+ populations is depicted. BF = brightfield micr
to compare Circular and Polymorph populations. Positive gating for each fluomononuclear cells had circular nuclei and variable
granularity, confirming their identity as NK cells. Fur-
ther, CD16+ NK cells did not express the macrophage
markers HLADRII or CD206 (Additional file 6: Figure S3),
nor did they express IL-1β, ACBA1, TLR2, TLR4,dipose tissue confirms flow cytometric phenotypic analysis.
Figure 3. After exclusion of non-nucleated cells and Hoechst saturating
ere gated on CD16+ cells. CD16+ cells (~30 cells for each group)
distinguish mononuclear (Circular, panel A) from polymorphonuclear
as used to identify similar cells in the total CD16+ source population
ted, panel D). Circularity and Bright Detail Intensity of the Hoechst
ed Polymorph and Circular cells. A plot of these 2 parameters for the
oscopy, Hoec = Hoechst nuclear staining. CD16 was plotted against SSC
rochrome parameter was established using FMO controls.
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(Additional file 7: Figure S4).
Psoriatic adipose NK cells are inversely related to obesity
To better understand how adipose immune cells relate
to obesity in psoriasis, we performed Spearman correl-
ation analyses between individual immune cell subset
frequencies and BMI. Both CD16-CD56Hi (r −0.552, p =
0.008) and CD16+CD56Lo NK cells (r −0.626, p = 0.002)
were inversely correlated with BMI in unadjusted ana-
lyses (Figure 6). The inverse relationship between BMI
(outcome variable) and adipose CD16+CD56Lo NK cells
remained significant after adjusting for the CMD risk
factors age, sex, diabetes, and tobacco use (β -46.5, p =
0.04), and with additional adjustment for treatment with
oral corticosteroids, DMARDs, and/or biologics (β -54.04,
p = 0.026). In contrast, BMI and CD16-CD56Hi NK cell
frequencies were no longer associated after adjustment for
CMD risk factors (β -1.89, p = 0.172). BMI was also unre-
lated to the other adipose immune cell types.
Comparison of adipose immune cells in psoriasis and
controls
To determine whether adipose immune cell composition
is affected by psoriasis, we performed a nested case–
control study (n = 6 non-diabetic control and psoriasis
patients) matched for age, sex, BMI, smoking, and dys-
lipidemia. We observed that CD16-CD56Hi NK cells, but
not other immune cells, were statistically greater (0.42%
live cells in psoriasis versus 0.06% live cells in controls,
p = 0.014) in psoriatic compared to control adipose.
While the frequencies of total ATM were similar in
psoriasis and controls (10.2% live cells in psoriasis versus
12.9% live cells in controls versus, p = 1.0), IL-1β produ-
cing (46.1% of psoriatic ATM versus 29.3% of control
ATM, p = 0.076) and IL-8 producing (66.1% of psoriatic
ATM versus 51.0% of control ATM, p = 0.175) ATM
were more abundant in psoriatic compared to control
adipose tissue. However, only the HLADRII+CD206+
ATM subset demonstrated a statistically significant dif-
ference in IL-1β (40.3% in psoriasis versus 19.6% inFigure 6 NK Cell frequencies in psoriatic adipose tissue are inversely
as in Figure 1. Relationships between frequencies of CD16+CD56Lo (left pan
determined using Spearman regression analysis. Regression plots and correcontrols, p = 0.047), but not IL-8 (62.5% in psoriasis ver-
sus 45.7% in controls, p = 0.117), production between
psoriatic and control adipose tissue.
Discussion
We utilized cutting-edge imaging technologies to demon-
strate that psoriatic adipose tissue contains immune cells
that may influence CMD in psoriasis. Using this approach,
we have: (1) identified previously unappreciated immune
cell populations and cell surface receptors (2) utilized a
combination of phenotypic markers and functional studies
to validate those populations (3) described an inverse rela-
tionship between psoriatic adipose CD16+CD56Lo NK
cells and obesity. We believe these studies take a critical
first step toward understanding CMD in psoriasis, and
may lead to novel therapies targeting these disorders.
Here, we distinguished 3 populations of ATM express-
ing varying levels of multi-functional receptors (CD36,
LOX-1, MSR1, RAGE, and TLR2) that may perform dual
roles in immunity and metabolism. For example, the
scavenger receptors MSR1 [37], CD36 [38], and LOX-1
[39] have been shown to bind modified LDL particles,
which play a prominent role in CMD and coronary
artery disease [40-43]. Furthermore, mRNA levels of
MSR1, CD36, and LOX-1 in whole adipose tissue speci-
mens have been associated with obesity and insulin re-
sistance in humans [44]. These pleiotropic scavenger
receptors also demonstrate important functions in in-
nate immune defense [45]. Similarly, RAGE [46,47] and
TLR2 [48,49] have essential roles in immunity and
CMD. Thus, our data support a growing body of litera-
ture indicating that macrophages may directly modulate
adipocyte function [50]. Our findings also suggest that
ATM populations may represent unique functional sub-
sets that respond to different stimuli, and extend well
beyond the oversimplified M1/M2 macrophage para-
digm [51-53]. This notion could be addressed by explor-
ing global gene expression patterns from purified ATM
populations both in the basal state and after activation
with various ligands. Importantly, we also demonstrated
that psoriatic ATM may be predisposed toward pro-correlated with BMI. Multi-parameter flow cytometry was performed
el) or CD16-CD56Hi (right panel) NK cells (x-axis) and BMI (y-axis) were
sponding r2 and p values are depicted.
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ute to adipose dysfunction in this disorder.
Several other populations of immune cells were identi-
fied using conventional and imaging flow cytometry. We
are the first to quantify frequencies of FoxP3+ Tregs [pre-
viously reported by FoxP3 mRNA expression [29,30]] and
γδ T cells in human adipose tissue. It is also noteworthy
that CD16+ cells were primarily neutrophils and NK cells.
Bourlier et al. previously found that up to 25% of ATM ex-
press CD16 [51]. However, control staining for CD16 was
not presented in their manuscript. In our experience,
staining with anti-CD16 antibodies in adipose tissue can
give high background signal and thus requires careful
antibody titration, Fc Receptor saturation, and appropriate
control stains. Both conventional and imaging flow cyto-
metric analyses confirmed that CD16 expression on ATM
is rare. Low frequencies of B cells [25], NKT cells [21], and
neutrophils [26,27] were also apparent in psoriatic adipose
tissue, confirming prior studies in humans. Adipose CD3+
T cells were predominantly αβ T cells and were largely
either effector or memory in phenotype, as previously
reported [25]. Consistent with previous reports [3,25],
CD4+ T cells were well represented followed in de-
scending order of frequency by CD8+ T cells, Tregs,
and γδ T cells. The nature of the cognate antigens
driving T cell priming locally and/or prior to migration
into adipose tissue remains to be determined.
Adipose NK cells may contribute to obesity in
humans. Two populations of NK cells have previously
been identified, and are designated as CD16-CD56Hi
[25,31,32] and CD16+CD56Lo [31] cells. We demon-
strated that the predominant CD16+CD56Lo NK cell
population correlated inversely with BMI in both un-
adjusted analyses and after adjustment for CMD risk fac-
tors and psoriasis treatment. These findings corroborate
those of O’Rourke et al., who demonstrated that the
CD16+CD56Lo subset was reduced in obese compared
to lean adipose tissue [31]. In contrast, these investiga-
tors found increased percentages of CD16-CD56Hi cells
in adipose tissue from obese compared to lean patients
[31], while Duffaut and colleagues reported no differences
in CD56+ NK cells (CD16 expression was not analyzed)
irrespective of BMI [25]. Despite these inconsistencies,
there is an inverse relationship between adiposity and the
major population of adipose NK cells (CD16+CD56Lo).
Future studies in animal models should directly test
whether NK cell deficiency impacts adipose tissue com-
position and function. Two indirect lines of evidence have
suggested this to be the case. First, studies of the NK cell
growth factor IL-15 have shown that IL-15 overexpression
increased adipose NK cell infiltration and decreased adi-
pose tissue mass in mice [54], although the latter outcome
may have been due to a direct effect of IL-15 on adipo-
cytes [55]. Second, leptin receptor mutant animalsdemonstrated lower circulating and tissue NK cell num-
bers and impaired NK cell function as well as prominent
obesity and insulin resistance [56]. Together, these studies
suggest that NK cells may protect against obesity in
mouse and man.
We acknowledge that this study had certain limitations
such as modest sample size and single-center study de-
sign, which could affect the generalizability of the results.
However, we provide unique data in 30 psoriatic patients
under standardized study conditions (NCT01778569). An-
other consideration is that therapies for psoriasis and/or
CMD could impact adipose tissue cell populations. Our
study used subcutaneous adipose tissue from psoriasis pa-
tients. While visceral adipose tissue is generally considered
to be more inflamed, recent studies have revealed that
subcutaneous and visceral adipose display a similar pro-
inflammatory phenotype, suggesting that experiments
using the readily accessible subcutaneous depot will en-
hance our understanding of adipose biology [57,58]. Des-
pite these limitations, our data are methodologically
sound and may be informative for understanding CMD in
psoriasis.
Conclusions
1) Advanced immunophenotyping will enhance our
understanding of adipose immune cell composition
and function in health and disease.
2) Immune cell characterization of psoriatic adipose
tissue may provide greater insight into CMD
pathophysiology in psoriasis.
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Additional file 1: Table S3. Antibodies Used for Flow Cytometry
Experiments.
Additional file 2: Table S1. Summary of immune cell populations in
psoriatic adipose tissue.
Additional file 3: Table S2. IL-1β and IL-8 Expression by Adipose Tissue
Macrophages.
Additional file 4: Figure S1. The majority of Tregs in psoriatic adipose
tissue are CD4+. Multi-parameter flow cytometry was performed as in
Figure 2. After sequentially gating out debris, doublets, and non-viable
cells, Treg cells were identified as CD3+CD16-CD19-CD56-TCRγδ-FoxP3+
cells. CD4+ and CD8+ Tregs from a representative sample are depicted
with cell frequencies presented as percentages of the parent population.
Positive gating for each fluorochrome parameter was established using
FMO controls.
Additional file 5: Figure S2. PD-1 is highly expressed on adipose tissue
B cells. Multi-parameter flow cytometry was performed as in Figure 2.
After sequentially gating out debris, doublets, and non-viable cells, B cells
were identified as CD3-CD16-CD19+CD56- cells with high surface expression
of the B cell marker PD-1. A representative sample is depicted, with cell
frequencies presented as percentages of the parent population. Positive
gating for each fluorochrome parameter was established using FMO controls.
Additional file 6: Figure S3. Specificity of adipose tissue macrophage
markers. Imaging flow cytometric analysis of psoriatic adipose tissue was
performed to determine the morphologic and staining characteristics of
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http://www.translational-medicine.com/content/12/1/258CD16+ cells delineated by flow cytometry (Figures 1 and 2). After
exclusion of non-nucleated cells and Hoechst saturating the camera,
poorly focused cells, and debris/doublets, CD3-CD14- cells were sub-gated
based on HLADRII (DRII) and CD206 staining. CD3-CD14+ cells were also
examined for CD16 expression. Cell frequencies are presented as
percentages of nucleated, focused, single cells. Positive gating for each
fluorochrome parameter was established using FMO controls.
Additional file 7: Figure S4. NK Cell phenotyping in psoriatic adipose
tissue. Multi-parameter flow cytometry was performed as in Figures 1
and 2. After sequentially gating out debris, doublets, and non-viable
cells, the vast majority (91-99%) of NK cells were identified as CD3-
CD14-CD16+CD19-CD56LoHLADRII- cells. NK cells were analyzed for
ABCA1, IL-1β, TLR2, TLR4, CD274, LOX-1, MSR1, CD36, RAGE, CD163, and
SR-B1 expression. NK cells from a representative sample are depicted
with cell frequencies presented as percentages of the parent population.
CD16+CD56Lo NK cells (red histograms) are presented compared to FMO
controls (blue histograms) for each fluorochrome parameter.
Abbreviations
ATM: Adipose tissue macrophages; BMI: Body mass index; BSA: Body surface
area; CMD: Cardiometabolic disease; DMARD: Disease-modifying anti-rheumatic
drug; ESR: Erythrocyte sedimentation rate; hsCRP: High-sensitivity C-reactive
protein; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; MFI: Mean
fluorescence intensity; PASI: Psoriasis area and severity index.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conception & Design of Study – SR, ES, PKD, LS, JPM, NNM. Data Acquisition,
Analysis, and Interpretation – SR, ES, PKD, LS, EW, AJ, JD, HN, MPP, NNM.
Drafting or Revision of Manuscript – SR, ES, PKD, LS, JPM, NNM. Final
Approval for Publication Granted - SR, ES, PKD, LS, EW, AJ, JD, HN, MPP, JPM,
NNM. Accountability for Accuracy and Integrity of the Work - SR, ES, PKD, LS,
EW, AJ, JD, HN, MPP, JPM, NNM.
Authors’ information
SR is an American Board of Internal Medicine certified rheumatologist,
member of the Group for the Assessment of Psoriasis and Psoriatic Arthritis
(GRAPPA), and a Metzger Clinical Scholar at the National Institutes of Health.
SR has extensive expertise in the clinical, basic, and translational mechanisms
linking inflammatory disorders to cardiovascular and metabolic disease.
ES is an Intramural Research Training Awardee (IRTA) at the National
Institutes of Health who specializes in flow cytometry.
PKD is a postdoctoral fellow at the National Institutes of Health with
significant expertise in flow cytometry, cell biology, and Th17 mediated
inflammatory diseases.
LS is a biologist in the National Heart Lung and Blood Institute Flow
Cytometry Core who is an expert in imaging flow cytometry.
EW is an Intramural Research Training Awardee (IRTA) at the National Institutes
of Health who specializes in adipose tissue procurement and biology.
AJ is a special volunteer at the National Heart Lung and Blood Institute who
specializes in adipose tissue procurement and biology.
JD is a biologist at the National Heart Lung and Blood Institute with significant
expertise in tissue processing and characterization and flow cytometry.
HBN is an American Board of Dermatology certified dermatologist with
extensive expertise in psoriasis, graft-versus host disease, and the neutrophilic
dermatoses. HBN is a senior clinical scholar at the National Cancer Institute.
MPP is a staff scientist at the National Heart Lung and Blood Institute who
specializes in cellular and molecular biology, lipid biology, vascular biology,
and Th17 mediated immune diseases.
JPM heads the National Heart Lung and Blood Institute Flow Cytometry Core
and is a key member of the Center for Human Immunology at the National
Institutes of Health. JPM is board certified in hematology by the American
Board of Bioanalysis and is licensed to direct clinical flow cytometry
laboratories in the states of New York and New Jersey. He has edited three
books on flow cytometry, is associate editor of Cytometry Part B: Clinical
Cytometry, and is past President of the Clinical Cytometry Society. JPM is
also a member of numerous professional societies including AACR, ASH, CCSand ASCP, and a recipient of the 2006 Lifetime Achievement Award from the
American Society of Clinical Pathology.
NNM is an American Board of Internal Medicine certified cardiologist who
specializes in preventative cardiology and cardiovascular imaging. He is the
inaugural Lasker Clinical Scholar and section chief in the Section of
Inflammation and Cardiometabolic Diseases at the National Heart, Lung, and
Blood Institute, National Institutes of Health. He is also a member of Group
for the Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and the
founder of the Psoriasis, Atherosclerosis, and Cardiometabolic Disease
Initiative (NCT01778569).
Acknowledgements
This work was funded using intramural funds from the National Heart Lung
and Blood Institute (NHLBI DIR grant HL006193-01), the National Institute of
Arthritis and Skin and Musculoskeletal Diseases, and the National Cancer
Institute.
Author details
1Section of Inflammation and Cardiometabolic Diseases, National Heart,
Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda,
MD, USA. 2National Institute of Arthritis and Musculoskeletal and Skin
Diseases (NIAMS), National Institutes of Health, Bethesda, MD, USA. 3Center
for Human Immunology, Autoimmunity, and Inflammation, National
Institutes of Health, Bethesda, MD, USA. 4Hematology Branch, NHLBI, National
Institutes of Health, Bethesda, MD, USA. 5National Cancer Institute (NCI),
National Institutes of Health, Bethesda, MD, USA. 6Cardiovascular and
Pulmonary Branch, NHLBI, 10 Center Drive, CRC, Room 5-5140, Bethesda, MD
20892, USA.
Received: 16 July 2014 Accepted: 9 September 2014
References
1. Garg SK, Delaney C, Shi H, Yung R: Changes in adipose tissue
macrophages and T cells during aging. Crit Rev Immunol 2014, 34:1–14.
2. Cildir G, Akincilar SC, Tergaonkar V: Chronic adipose tissue inflammation:
all immune cells on the stage. Trends Mol Med 2013, 19:487–500.
3. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M,
Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, Hauner H, Bluher M, Unger
T, Wolf AM, Knippschild U, Hornback V, Marx N: T-lymphocyte infiltration in
visceral adipose tissue: a primary event in adipose tissue inflammation
and the development of obesity-mediated insulin resistance. Arterioscler
Thromb Vasc Biol 2008, 28:1304–1310.
4. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M,
Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R: CD8+ effector
T cells contribute to macrophage recruitment and adipose tissue
inflammation in obesity. Nat Med 2009, 15:914–920.
5. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, Libby P:
Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for
adaptive immunity in obesity. Circ Res 2008, 103:467–476.
6. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y,
Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D,
Dosch HM: Normalization of obesity-associated insulin resistance through
immunotherapy. Nat Med 2009, 15:921–929.
7. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, Sweeney JF,
Peterson LE, Chan L, Smith CW, Ballantyne CM: T-cell accumulation and
regulated on activation, normal T cell expressed and secreted
upregulation in adipose tissue in obesity. Circulation 2007, 115:1029–1038.
8. Duffaut C, Galitzky J, Lafontan M, Bouloumie A: Unexpected trafficking of
immune cells within the adipose tissue during the onset of obesity.
Biochem Biophys Res Commun 2009, 384:482–485.
9. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P,
Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA,
Tedder TF, McLaughlin T, Miklos DB, Dosch HM, Engelman EG: B cells
promote insulin resistance through modulation of T cells and
production of pathogenic IgG antibodies. Nat Med 2011, 17:610–617.
10. Bertola A, Ciucci T, Rousseau D, Bourlier V, Duffaut C, Bonnafous S, Blin-
Wakkach C, Anty R, Iannelli A, Gugenheim J, Tran A, Bouloumie A, Gual P,
Wakkach A: Identification of adipose tissue dendritic cells correlated with
obesity-associated insulin-resistance and inducing Th17 responses in
mice and patients. Diabetes 2012, 61:2238–2247.
Rose et al. Journal of Translational Medicine 2014, 12:258 Page 12 of 13
http://www.translational-medicine.com/content/12/1/25811. Stefanovic-Racic M, Yang X, Turner MS, Mantell BS, Stolz DB, Sumpter TL,
Sipula IJ, Dedousis N, Scott DK, Morel PA, Thomson AW, O’Doherty RM:
Dendritic cells promote macrophage infiltration and comprise a
substantial proportion of obesity-associated increases in CD11c+ cells in
adipose tissue and liver. Diabetes 2012, 61:2330–2339.
12. Elgazar-Carmon V, Rudich A, Hadad N, Levy R: Neutrophils transiently
infiltrate intra-abdominal fat early in the course of high-fat feeding.
J Lipid Res 2008, 49:1894–1903.
13. Talukdar S, Oh da Y, Bandyopadhyay G, Li D, Xu J, McNelis J, Lu M, Li P, Yan
Q, Zhu Y, Ofrecio J, Lin M, Brenner MB, Olefsky JM: Neutrophils mediate
insulin resistance in mice fed a high-fat diet through secreted elastase.
Nat Med 2012, 18:1407–1412.
14. Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN, Sukhova GK,
Wolters PJ, Du J, Gorgun CZ, Doria A, Libby P, Blumberg RS, Kahn BB,
Hotamisligil GS, Shi GP: Genetic deficiency and pharmacological
stabilization of mast cells reduce diet-induced obesity and diabetes in
mice. Nat Med 2009, 15:940–945.
15. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG: Ablation of
CD11c-positive cells normalizes insulin sensitivity in obese insulin
resistant animals. Cell Metab 2008, 8:301–309.
16. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr:
Obesity is associated with macrophage accumulation in adipose tissue.
J Clin Invest 2003, 112:1796–1808.
17. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS,
Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in
the development of obesity-related insulin resistance. J Clin Invest 2003,
112:1821–1830.
18. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK,
Chawla A, Locksley RM: Eosinophils sustain adipose alternatively activated
macrophages associated with glucose homeostasis. Science 2011,
332:243–247.
19. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine
AB, Benoist C, Shoelson S, Mathis D: Lean, but not obese, fat is enriched
for a unique population of regulatory T cells that affect metabolic
parameters. Nat Med 2009, 15:930–939.
20. Ilan Y, Maron R, Tukpah AM, Maioli TU, Murugaiyan G, Yang K, Wu HY,
Weiner HL: Induction of regulatory T cells decreases adipose
inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl
Acad Sci U S A 2010, 107:9765–9770.
21. Ji Y, Sun S, Xu A, Bhargava P, Yang L, Lam KS, Gao B, Lee CH, Kersten S, Qi L:
Activation of natural killer T cells promotes M2 Macrophage polarization
in adipose tissue and improves systemic glucose tolerance via
interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem
2012, 287:13561–13571.
22. Mantell BS, Stefanovic-Racic M, Yang X, Dedousis N, Sipula IJ, O’Doherty RM:
Mice lacking NKT cells but with a complete complement of CD8+ T-cells
are not protected against the metabolic abnormalities of diet-induced
obesity. PLoS One 2011, 6:e19831.
23. Schipper HS, Rakhshandehroo M, van de Graaf SF, Venken K, Koppen A,
Stienstra R, Prop S, Meerding J, Hamers N, Besra G, Boon L, Nieuwenhuis EE,
Elewaut D, Prakken B, Kersten S, Boes M, Kalkhoven E: Natural killer T cells
in adipose tissue prevent insulin resistance. J Clin Invest 2012,
122:3343–3354.
24. Wu L, Parekh VV, Gabriel CL, Bracy DP, Marks-Shulman PA, Tamboli RA, Kim
S, Mendez-Fernandez YV, Besra GS, Lomenick JP, Williams B, Wasserman BH,
Van Kaer L: Activation of invariant natural killer T cells by lipid excess
promotes tissue inflammation, insulin resistance, and hepatic steatosis in
obese mice. Proc Natl Acad Sci U S A 2012, 109:E1143–E1152.
25. Duffaut C, Zakaroff-Girard A, Bourlier V, Decaunes P, Maumus M, Chiotasso
P, Sengenes C, Lafontan M, Galitzky J, Bouloumie A: Interplay between
human adipocytes and T lymphocytes in obesity: CCL20 as an
adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler
Thromb Vasc Biol 2009, 29:1608–1614.
26. Rouault C, Pellegrinelli V, Schilch R, Cotillard A, Poitou C, Tordjman J, Sell H,
Clement K, Lacasa D: Roles of chemokine ligand-2 (CXCL2) and neutrophils
in influencing endothelial cell function and inflammation of human adipose
tissue. Endocrinology 2013, 154:1069–1079.
27. Shah TJ, Leik CE, Walsh SW: Neutrophil infiltration and systemic vascular
inflammation in obese women. Reprod Sci 2010, 17:116–124.
28. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, Bouloumie A:
From blood monocytes to adipose tissue-resident macrophages:induction of diapedesis by human mature adipocytes. Diabetes 2004,
53:1285–1292.
29. Zeyda M, Huber J, Prager G, Stulnig TM: Inflammation correlates with
markers of T-cell subsets including regulatory T cells in adipose tissue
from obese patients. Obesity (Silver Spring) 2011, 19:743–748.
30. Deiuliis J, Shah Z, Shah N, Needleman B, Mikami D, Narula V, Perry K, Hazey
J, Kampfrath T, Kollengode M, Sun Q, Satoskar AR, Lumeng C, Moffatt-Bruce
S, Rajagopalan S: Visceral adipose inflammation in obesity is associated
with critical alterations in tregulatory cell numbers. PLoS One 2011,
6:e16376.
31. O’Rourke RW, Gaston GD, Meyer KA, White AE, Marks DL: Adipose tissue NK
cells manifest an activated phenotype in human obesity. Metabolism
2013, 62:1557–1561.
32. O’Rourke RW, Metcalf MD, White AE, Madala A, Winters BR, Maizlin II, Jobe
BA, Roberts CT Jr, Slifka MK, Marks DL: Depot-specific differences in
inflammatory mediators and a role for NK cells and IFN-gamma in
inflammation in human adipose tissue. Int J Obes (Lond) 2009, 33:978–990.
33. Armstrong AW, Harskamp CT, Armstrong EJ: Psoriasis and metabolic
syndrome: a systematic review and meta-analysis of observational
studies. J Am Acad Dermatol 2013, 68:654–662.
34. Li RC, Krishnamoorthy P, DerOhannessian S, Doveikis J, Wilcox M, Thomas P,
Rader DJ, Reilly MP, Van Voorhees A, Gelfand JM, Mehta NN: Psoriasis is
associated with decreased plasma adiponectin levels independently of
cardiometabolic risk factors. Clin Exp Dermatol 2014, 39:19–24.
35. Basiji DA, Ortyn WE, Liang L, Venkatachalam V, Morrissey P: Cellular
image analysis and imaging by flow cytometry. Clin Lab Med 2007,
27:653–670. viii.
36. Yan J, Ralston MM, Meng X, Bongiovanni KD, Jones AL, Benndorf R, Nelin
LD, Joshua Frazier W, Rogers LK, Smith CV, Liu Y: Glutathione reductase is
essential for host defense against bacterial infection. Free Radic Biol Med
2013, 61C:320–332.
37. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that
mediates uptake and degradation of acetylated low density lipoprotein,
producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979,
76:333–337.
38. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA:
CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993,
268:11811–11816.
39. Hoshikawa H, Sawamura T, Kakutani M, Aoyama T, Nakamura T, Masaki T:
High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL
receptor (LOX-1). Biochem Biophys Res Commun 1998, 245:841–846.
40. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T,
Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J,
Becker AR: Elevated levels of oxidized low density lipoprotein show a
positive relationship with the severity of acute coronary syndromes.
Circulation 2001, 103:1955–1960.
41. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D: Oxidized LDL
and malondialdehyde-modified LDL in patients with acute coronary
syndromes and stable coronary artery disease. Circulation 1998,
98:1487–1494.
42. Porreca E, Di Febbo C, Moretta V, Angelini A, Guglielmi MD, Di Nisio M,
Cuccurullo F: Circulating leptin is associated with oxidized LDL in
postmenopausal women. Atherosclerosis 2004, 175:139–143.
43. Sigurdardottir V, Fagerberg B, Hulthe J: Circulating oxidized low-density
lipoprotein (LDL) is associated with risk factors of the metabolic
syndrome and LDL size in clinically healthy 58-year-old men (AIR study).
J Intern Med 2002, 252:440–447.
44. Rasouli N, Yao-Borengasser A, Varma V, Spencer HJ, McGehee RE Jr, Peterson
CA, Mehta JL, Kern PA: Association of scavenger receptors in adipose
tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb
Vasc Biol 2009, 29:1328–1335.
45. Peiser L, Mukhopadhyay S, Gordon S: Scavenger receptors in innate
immunity. Curr Opin Immunol 2002, 14:123–128.
46. Chuah YK, Basir R, Talib H, Tie TH, Nordin N: Receptor for Advanced
Glycation End Products and Its Involvement in Inflammatory Diseases.
Int J Inflam 2013, 2013:403460.
47. van Zoelen MA, Achouiti A, van der Poll T: RAGE during infectious
diseases. Front Biosci (Schol Ed) 2011, 3:1119–1132.
48. Jialal I, Kaur H, Devaraj S: Toll-like receptor status in obesity and metabolic
syndrome: a translational perspective. J Clin Endocrinol Metab 2014,
99:39–48.
Rose et al. Journal of Translational Medicine 2014, 12:258 Page 13 of 13
http://www.translational-medicine.com/content/12/1/25849. Oliveira-Nascimento L, Massari P, Wetzler LM: The Role of TLR2 in Infection
and Immunity. Front Immunol 2012, 3:79.
50. Sorisky A, Molgat AS, Gagnon A: Macrophage-induced adipose tissue
dysfunction and the preadipocyte: should I stay (and differentiate) or
should I go? Adv Nutr 2013, 4:67–75.
51. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes
C, Galitzky J, Lafontan M, Karpe F, Frayn KN, Bouloumie A: Remodeling
phenotype of human subcutaneous adipose tissue macrophages.
Circulation 2008, 117:806–815.
52. Fjeldborg K, Pedersen SB, Moller HJ, Christiansen T, Bennetzen M, Richelsen
B: Human adipose tissue macrophages are enhanced but changed to an
anti-inflammatory profile in obesity. J Immunol Res 2014, 2014:309548.
53. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G, Zlabinger GJ,
Stulnig TM: Human adipose tissue macrophages are of an anti-
inflammatory phenotype but capable of excessive pro-inflammatory
mediator production. Int J Obes (Lond) 2007, 31:1420–1428.
54. Barra NG, Reid S, MacKenzie R, Werstuck G, Trigatti BL, Richards C, Holloway
AC, Ashkar AA: Interleukin-15 contributes to the regulation of murine
adipose tissue and human adipocytes. Obesity (Silver Spring) 2010,
18:1601–1607.
55. Barra NG, Chew MV, Reid S, Ashkar AA: Interleukin-15 treatment induces
weight loss independent of lymphocytes. PLoS One 2012, 7:e39553.
56. Tian Z, Sun R, Wei H, Gao B: Impaired natural killer (NK) cell activity in
leptin receptor deficient mice: leptin as a critical regulator in NK cell
development and activation. Biochem Biophys Res Commun 2002,
298:297–302.
57. Shah R, Lu Y, Hinkle CC, McGillicuddy FC, Kim R, Hannenhalli S, Cappola TP,
Heffron S, Wang X, Mehta NN, Putt M, Reilly MP: Gene profiling of human
adipose tissue during evoked inflammation in vivo. Diabetes 2009,
58:2211–2219.
58. Dolinkova M, Dostalova I, Lacinova Z, Michalsky D, Haluzikova D, Mraz M,
Kasalicky M, Haluzik M: The endocrine profile of subcutaneous and
visceral adipose tissue of obese patients. Mol Cell Endocrinol 2008,
291:63–70.
doi:10.1186/s12967-014-0258-2
Cite this article as: Rose et al.: Characterization of immune cells in
psoriatic adipose tissue. Journal of Translational Medicine 2014 12:258.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
